Updates are available Correction dated 2024-06-20
Click to view Correction: https://doi.org/10.1007/s00259-024-06792-w
-
Authors
Altunay, Betül
Morgenroth, Agnieszka
Beheshti, Mohsen
Vogg, Andreas
Wong, Nicholas C. L.
Ting, Hong Hoi
Biersack, Hans-Jürgen
Stickeler, Elmar
Mottaghy, Felix M. http://orcid.org/0000-0002-7212-6521
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (331065168)
Horizon 2020 (722609)
Nanomab (unrestricted grant)
Deutsche Krebshilfe (70113779)
- License Information
-
More Information
Article History
Received: 26 August 2020
Accepted: 26 October 2020
First Online: 12 November 2020
Change Date: 20 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00259-024-06792-w
Compliance with ethical standards
:
: Nicholas Wong and Hong Hoi Ting are employed by Nanomab Technologies. All other authors declare no conflict of interest with the content of this review.
